Related content

The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin

By Rakotoniaina Zo   Guerard Pascal   Lirussi Frederic   Goirand Françoise   Rochette Luc   Dumas Monique   Bardou Marc  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 3, 2006-12 ,pp. : 195-206

Springer Publishing Company

Access to resources Recommend Favorite

Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat

By Rakotoniaina Zo  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 378, Iss. 3, 2008-09 ,pp. : 241-251

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of eNOS prevents the development of renovascular hypertension in mice

By Gava Agata L.   Peotta Veronica A.   Cabral Antonio M.   Vasquez Elisardo C.   Meyrelles Silvana S.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 7, 2008-07 ,pp. : 458-464

NRC Research Press

Access to resources Recommend Favorite

Intestinal Absorption of HMG-CoA Reductase Inhibitor Pravastatin Mediated by Organic Anion Transporting Polypeptide

By Shirasaka Yoshiyuki   Suzuki Kensuke   Nakanishi Takeo   Tamai Ikumi  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2141-2149

Springer Publishing Company

Access to resources Recommend Favorite

Hemin Treatment Abrogates Monocrotaline-Induced Pulmonary Hypertension

By  

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 572-576

Bentham Science Publishers

Access to resources Recommend Favorite